Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis

被引:31
作者
Kitami, Kazuhisa [1 ]
Yoshihara, Masato [1 ]
Tamauchi, Satoshi [1 ]
Sugiyama, Mai [2 ]
Koya, Yoshihiro [2 ]
Yamakita, Yoshihiko [2 ]
Fujimoto, Hiroki [1 ,3 ]
Iyoshi, Shohei [1 ,4 ]
Uno, Kaname [1 ,5 ]
Mogi, Kazumasa [1 ]
Ikeda, Yoshiki [1 ]
Yokoi, Akira [1 ,6 ]
Yoshikawa, Nobuhisa [1 ]
Nishino, Kimihiro [1 ]
Niimi, Kaoru [1 ]
Nawa, Akihiro [2 ]
Enomoto, Atsushi [7 ]
Kajiyama, Hiroaki [1 ]
机构
[1] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ, Bell Res Ctr, Dept Obstet & Gynecol Collaborat Res, Grad Sch Med, Nagoya, Aichi, Japan
[3] Univ Adelaide, Adelaide Med Sch, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia
[4] Univ Freiburg, Spemann Grad Sch Biol & Med, Albertstr, Freiburg, Germany
[5] Lund Univ, Div Clin Genet, Lund, Sweden
[6] Nagoya Univ, Inst Adv Res, Nagoya, Aichi, Japan
[7] Nagoya Univ, Dept Pathol, Grad Sch Med, Nagoya, Aichi, Japan
基金
日本学术振兴会;
关键词
Ovarian cancer; Peritoneum; Metastasis; Thrombospondin-1; Vitamin D; Epithelial-mesenchymal transition (EMT); TO-MESENCHYMAL TRANSITION; MESOTHELIAL CELLS; D-RECEPTOR; THERAPEUTIC TARGET; EXPRESSION; THROMBOSPONDIN-1; SUPPLEMENTATION; FIBROBLASTS; METASTASIS; SUPPRESSES;
D O I
10.1016/j.matbio.2022.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ovarian cancer (OvCa), a lethal gynecological malignancy, disseminates to the peritoneum. Mesothelial cells (MCs) act as barriers in the abdominal cavity, preventing the adhesion of cancer cells. However, in patients with OvCa, they are transformed into cancer-associated mesothelial cells (CAMs) via mesenchymal transition and form a favorable microenvironment for tumors to promote metastasis. However, attempts for restoring CAMs to their original state have been limited. Here, we investigated whether inhibition of mesenchymal transition and restoration of MCs by vitamin D suppressed the OvCa dissemination in vitro and in vivo. The effect of vitamin D on the mutual association of MCs and OvCa cells was evaluated using in vitro coculture models and in vivo using a xenograft model. Vitamin D restored the CAMs, and thrombospondin-1 (component of the extracellular matrix that is clinically associated with poor prognosis and is highly expressed in peritoneally metastasized OvCa) was found to promote OvCa cell adhesion and proliferation. Mechanistically, TGF-beta 1 secreted from OvCa cells enhanced thrombospondin-1 expression in CAMs via Smad-dependent TGF-beta signaling. Vitamin D inhibited mesenchymal transition in MCs and suppressed thrombospondin-1 expression via vitamin D receptor/Smad3 competition, contributing to the marked reduction in peritoneal dissemination in vivo. Importantly, vitamin D restored CAMs from a stabilized mesenchymal state to the epithelial state and normalized thrombospondin-1 expression in preclinical models that mimic cancerous peritonitis in vivo. MCs are key players in OvCa dissemination and peritoneal restoration and normalization of thrombospondin-1 expression by vitamin D may be a novel strategy for preventing OvCa dissemination. (C) 2022 The Author(s). Published by Elsevier B.V. This
引用
收藏
页码:70 / 90
页数:21
相关论文
共 63 条
[1]   Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination [J].
Abe, Toshiya ;
Ohuchida, Kenoki ;
Koikawa, Kazuhiro ;
Endo, Sho ;
Okumura, Takashi ;
Sada, Masafumi ;
Horioka, Kohei ;
Zheng, Biao ;
Moriyama, Taiki ;
Nakata, Kohei ;
Miyasaka, Yoshihiro ;
Manabe, Tatsuya ;
Ohtsuka, Takao ;
Nagai, Eishi ;
Mizumoto, Kazuhiro ;
Hashizume, Makoto ;
Nakamura, Masafumi .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (02) :457-467
[2]   Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial [J].
Akiba, Tadashi ;
Morikawa, Toshiaki ;
Odaka, Makoto ;
Nakada, Takeo ;
Kamiya, Noriki ;
Yamashita, Makoto ;
Yabe, Mitsuo ;
Inagaki, Takuya ;
Asano, Hisatoshi ;
Mori, Shohei ;
Tsukamoto, Yo ;
Urashima, Mitsuyoshi .
CLINICAL CANCER RESEARCH, 2018, 24 (17) :4089-4097
[3]   Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice [J].
Bouillon, Roger ;
Carmeliet, Geert ;
Verlinden, Lieve ;
van Etten, Evelyne ;
Verstuyf, Annemieke ;
Luderer, Hilary F. ;
Lieben, Liesbet ;
Mathieu, Chantal ;
Demay, Marie .
ENDOCRINE REVIEWS, 2008, 29 (06) :726-776
[4]   Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease [J].
Brodsky, Alexander S. ;
Fischer, Andrew ;
Miller, Daniel H. ;
Vang, Souriya ;
MacLaughlan, Shannon ;
Wu, Hsin-Ta ;
Yu, Jovian ;
Steinhoff, Margaret ;
Collins, Colin ;
Smith, Peter J. S. ;
Raphael, Benjamin J. ;
Brard, Laurent .
PLOS ONE, 2014, 9 (04)
[5]   A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response [J].
Ding, Ning ;
Yu, Ruth T. ;
Subramaniam, Nanthakumar ;
Sherman, Mara H. ;
Wilson, Caroline ;
Rao, Renuka ;
Leblanc, Mathias ;
Coulter, Sally ;
He, Mingxiao ;
Scott, Christopher ;
Lau, Sue L. ;
Atkins, Annette R. ;
Barish, Grant D. ;
Gunton, Jenny E. ;
Liddle, Christopher ;
Downes, Michael ;
Evans, Ronald M. .
CELL, 2013, 153 (03) :601-613
[6]   Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts [J].
Eckert, Mark A. ;
Coscia, Fabian ;
Chryplewicz, Agnieszka ;
Chang, Jae Won ;
Hernandez, Kyle M. ;
Pan, Shawn ;
Tienda, Samantha M. ;
Nahotko, Dominik A. ;
Li, Gang ;
Blazenovic, Ivana ;
Lastra, Ricardo R. ;
Curtis, Marion ;
Yamada, S. Diane ;
Perets, Ruth ;
McGregor, Stephanie M. ;
Andrade, Jorge ;
Fiehn, Oliver ;
Moellering, Raymond E. ;
Mann, Matthias ;
Lengyel, Ernst .
NATURE, 2019, 569 (7758) :723-+
[7]   The role of vitamin D in reducing cancer risk and progression [J].
Feldman, David ;
Krishnan, Aruna V. ;
Swami, Srilatha ;
Giovannucci, Edward ;
Feldman, Brian J. .
NATURE REVIEWS CANCER, 2014, 14 (05) :342-357
[8]   Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer [J].
Ferrer-Mayorga, Gemma ;
Gomez-Lopez, Gonzalo ;
Barbachano, Antonio ;
Fernandez-Barral, Asuncion ;
Pena, Cristina ;
Pisano, David G. ;
Cantero, Ramon ;
Rojo, Federico ;
Munoz, Alberto ;
Larriba, Maria Jesus .
GUT, 2017, 66 (08) :1449-1462
[9]  
Foley-Comer AJ, 2002, J CELL SCI, V115, P1383
[10]   A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies [J].
Fountzilas, Christos ;
Javle, Milind ;
Tan, Wei ;
Ma, Yingyu ;
Fetterly, Gerald ;
Iyer, Renuka ;
Johnson, Candace .
CANCER, 2018, 124 (19) :3890-3899